Published in Dermatology on January 01, 1998
A study on cercarial dermatitis in Khuzestan province, south western Iran. BMC Public Health (2003) 1.18
Avian schistosomes and outbreaks of cercarial dermatitis. Clin Microbiol Rev (2015) 0.86
Cercarial dermatitis and lake eutrophication in south-central Chile. Epidemiol Infect (2007) 0.85
Molluscs for Sale: Assessment of Freshwater Gastropods and Bivalves in the Ornamental Pet Trade. PLoS One (2016) 0.81
Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet (2001) 2.72
Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil. Br J Dermatol (1999) 1.96
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol (1998) 1.73
Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med (1992) 1.72
Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol (1998) 1.70
Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol (1999) 1.69
Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry as a tool for rapid diagnosis of potentially toxigenic Corynebacterium species in the laboratory management of diphtheria-associated bacteria. Euro Surveill (2010) 1.60
Psychodermatological aspects of atopic dermatitis. Br J Dermatol (2014) 1.59
The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol (2006) 1.55
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49
Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br J Dermatol (2002) 1.42
The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy (2004) 1.42
Conservative management of biliary obstruction due to Fasciola hepatica. Clin Infect Dis (2000) 1.40
[Pyoderma]. Hautarzt (1998) 1.37
Influence of serum protein binding on the in vitro activity of anti-fungal agents. Infection (1996) 1.23
Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill (2012) 1.23
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion. Ann Oncol (2010) 1.20
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol (2004) 1.19
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol (2009) 1.19
Late cutaneous schistosomiasis representing an isolated skin manifestation of schistosoma mansoni infection. Dermatology (2000) 1.19
Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib. Ann Oncol (2007) 1.17
[Normal pH value of human skin]. Hautarzt (1986) 1.16
Contribution of the Mn-cofactored superoxide dismutase (SodA) to the virulence of Yersinia enterocolitica serotype O8. Infect Immun (1997) 1.16
Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect Immun (1993) 1.14
Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study. Antimicrob Agents Chemother (1991) 1.13
Chronic prosthetic hip infection caused by a small-colony variant of Escherichia coli. J Clin Microbiol (1998) 1.08
Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol (1995) 1.07
Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J Invest Dermatol (2000) 1.07
Inherited IL-12 unresponsiveness contributes to the high LPS resistance of the Lps(d) C57BL/10ScCr mouse. J Immunol (2001) 1.04
Characterisation of penicillinase producing gonococci isolated in Munich, 1981-6. Genitourin Med (1988) 1.02
1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol (2001) 0.99
[Morphologic variants of genital ulcer caused by Haemophilus ducreyi]. Hautarzt (1989) 0.99
Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration. J Am Acad Dermatol (1990) 0.98
The role of vitamin E in normal and damaged skin. J Mol Med (Berl) (1995) 0.97
The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J Mol Med (Berl) (1996) 0.96
Molecular diagnosis of an Enterocytozoon bieneusi human genotype C infection in a moderately immunosuppressed human immunodeficiency virus seronegative liver-transplant recipient with severe chronic diarrhea. J Clin Microbiol (2001) 0.96
Antimicrobial susceptibility testing of dermatophytes--comparison of the agar macrodilution and broth microdilution tests. Chemotherapy (1998) 0.96
Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int J Cosmet Sci (2007) 0.95
Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts. Int J Antimicrob Agents (2001) 0.95
Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro (2005) 0.95
Cefodizime penetration into skin suction blister fluid following a single intravenous dose. Eur J Clin Pharmacol (1986) 0.95
Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI. J Immunol (1995) 0.94
Onychomycosis. Mycoses (2007) 0.94
The KEX2 gene of Candida glabrata is required for cell surface integrity. Mol Microbiol (2001) 0.94
Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol (2000) 0.94
Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica. Infect Immun (2000) 0.93
Treatment of atopic eczema with oral alitretinoin. Br J Dermatol (2009) 0.93
Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects. Skin Pharmacol Physiol (2004) 0.92
A multiplex one-step real-time RT-PCR assay for influenza surveillance. Euro Surveill (2011) 0.92
Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern. Allergy (2014) 0.92
Single-nucleotide polymorphism in the SCCmec-orfX junction distinguishes between livestock-associated MRSA CC398 and human epidemic MRSA strains. Euro Surveill (2009) 0.92
Plasmid content and protein I serovar of non-penicillinase-producing gonococci isolated in Munich. Epidemiol Infect (1988) 0.92
Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol (2005) 0.91
In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol (1999) 0.91
The use of systemic antimycotics in dermatotherapy. Eur J Dermatol (2000) 0.91
Preputial abscesses caused by beta-lactamase-producing gonococci. Cutis (1985) 0.90
Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release (2005) 0.90
Interferon beta, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice. J Exp Med (1995) 0.89
Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages. Med Microbiol Immunol (1999) 0.89
Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. J Eur Acad Dermatol Venereol (2006) 0.89
Proactive therapy of atopic dermatitis--an emerging concept. Allergy (2008) 0.89
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia. J Eur Acad Dermatol Venereol (2009) 0.89
Liposomes: a drug carrier system for topical treatment in dermatology. Crit Rev Ther Drug Carrier Syst (1994) 0.89
[The correlation between biotype and antifungal sensitivity of Candida albicans]. Mykosen (1987) 0.89
Influence of repeated washings with soap and synthetic detergents on pH and resident flora of the skin of forehead and forearm. Results of a cross-over trial in health probationers. Acta Derm Venereol (1987) 0.88
In situ expression of the costimulatory molecules CD80 and CD86 on langerhans cells and inflammatory dendritic epidermal cells (IDEC) in atopic dermatitis. Arch Dermatol Res (2001) 0.88
Phospholipases of Candida albicans. Mycoses (2001) 0.88
RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie (2005) 0.88
In vitro activity of eight antimicrobial agents against non-penicillinase-producing gonococci isolated in Munich. Genitourin Med (1988) 0.87
Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years. Mycoses (1999) 0.87
Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target (2002) 0.87
HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study. Mycoses (1999) 0.87
Induction of CD14 expression in Lpsn, Lpsd and tumor necrosis factor receptor-deficient mice. Eur J Immunol (1996) 0.87
Human plasma and skin blister fluid levels of griseofulvin following a single oral dose. Eur J Clin Pharmacol (1985) 0.87
Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G. Chemotherapy (1984) 0.86
Development of a duplex real-time PCR for differentiation between E. coli and Shigella spp. J Appl Microbiol (2011) 0.86
Management of onychomycoses. Drugs (1999) 0.86
Cutaneous side-effects of EGFR inhibitors and their management. Skin Therapy Lett (2011) 0.86
Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo. Chemotherapy (1984) 0.86
Detection of herpes simplex virus in exacerbated pemphigus vulgaris by polymerase chain reaction. Dermatology (1996) 0.85
Interleukin-12 and interleukin-18 are indispensable for protective immunity against enteropathogenic Yersinia. Microb Pathog (2001) 0.85
A human bite. Lancet (1999) 0.85
Prevalence of gonococci lacking the 2.6 megadalton cryptic plasmid. Lancet (1987) 0.85
Reconciling the concepts of endotoxin sensitization and tolerance. Prog Clin Biol Res (1998) 0.85
Ketoconazole concentrations in human skin blister fluid and plasma. Int J Clin Pharmacol Ther Toxicol (1984) 0.85
Does cantharides blister fluid provide access to the peripheral compartment? Eur J Clin Pharmacol (1982) 0.85
Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol (2005) 0.85
[Antimicrobial effects of in vitro-simulated ketoconazole-cantharidin blister fluid levels on candida albicans]. Mykosen (1986) 0.84
Evaluation of cefotetan in uncomplicated gonorrhea. Dermatologica (1986) 0.84
Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid. Acta Derm Venereol Suppl (Stockh) (1992) 0.84
Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis. Mycoses (1994) 0.84
Effect of iron limitation on protein composition and ultrastructure of Haemophilus ducreyi. FEMS Microbiol Lett (1990) 0.84
Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J Mol Med (Berl) (2000) 0.83
Innate immune receptors on neutrophils and their role in chronic lung disease. Eur J Clin Invest (2009) 0.83
Reflectance confocal microscopy in the diagnosis of partially and completely amelanotic melanoma: report on seven cases. J Eur Acad Dermatol Venereol (2012) 0.83
Immunohistochemical investigations of genital ulcers caused by Haemophilus ducreyi. Int J STD AIDS (1997) 0.83
Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis. Br J Dermatol (2000) 0.83
Penciclovir cream--improved topical treatment for herpes simplex infections. Skin Pharmacol Physiol (2004) 0.83